BRMS1L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.266000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.342400E-01
Normal-vs-Stage2
8.800000E-01
Normal-vs-Stage3
3.644600E-01
Normal-vs-Stage4
5.236200E-01
Stage1-vs-Stage2
7.404400E-01
Stage1-vs-Stage3
3.146200E-01
Stage1-vs-Stage4
6.641400E-01
Stage2-vs-Stage3
3.477400E-01
Stage2-vs-Stage4
3.530600E-01
Stage3-vs-Stage4
2.384400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.999800E-01
Normal-vs-AfricanAmerican
7.428000E-01
Normal-vs-Asian
3.822400E-01
Caucasian-vs-AfricanAmerican
8.234600E-01
Caucasian-vs-Asian
7.071900E-02
AfricanAmerican-vs-Asian
1.718630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.619400E-01
Normal-vs-Female
7.742400E-01
Male-vs-Female
6.966000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.939000E-01
Normal-vs-Age(41-60Yrs)
4.765400E-01
Normal-vs-Age(61-80Yrs)
9.745200E-01
Normal-vs-Age(81-100Yrs)
6.221600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.765800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.832400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.053600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.905000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.504900E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.597600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.491800E-01
Normal-vs-Daily Drinker
9.627000E-01
Normal-vs-Weekly Drinker
9.725000E-01
Normal-vs-Occasional Drinker
4.757000E-01
Normal-vs-Social Drinker
7.770800E-01
Non Drinker-vs-Daily Drinker
4.251800E-01
Non Drinker-vs-Weekly Drinker
4.824800E-01
Non Drinker-vs-Occasional Drinker
3.084100E-02
Non Drinker-vs-Social Drinker
2.456800E-01
Daily Drinker-vs-Weekly Drinker
9.873200E-01
Daily Drinker-vs-Occasional Drinker
1.015410E-01
Daily Drinker-vs-Social Drinker
4.955000E-01
Weekly Drinker-vs-Occasional Drinker
1.724230E-01
Weekly Drinker-vs-Social Drinker
5.732800E-01
Occasional Drinker-vs-Social Drinker
4.679600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.042000E-01
Normal-vs-Grade 2
4.203600E-01
Normal-vs-Grade 3
4.099400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.785800E-01
Grade 1-vs-Grade 3
7.960200E-01
Grade 1-vs-Grade 4
5.042000E-01
Grade 2-vs-Grade 3
5.782600E-01
Grade 2-vs-Grade 4
4.203600E-01
Grade 3-vs-Grade 4
4.099400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.381000E-01
Normal-vs-NonDiabetic
8.798400E-01
Diabetic-vs-NonDiabetic
4.776800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.517500E-02
Normal-vs-NoPancreatitis
8.117400E-01
Pancreatitis-vs-NoPancreatitis
3.978500E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.965800E-01
Normal-vs-N1
8.278400E-01
N0-vs-N1
7.884000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.173400E-01
Normal-vs-TP53-NonMutant
7.147200E-01
TP53-Mutant-vs-TP53-NonMutant
6.292600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
